• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿尔茨海默病痴呆患者的家属注意到,患者的定向障碍和视觉记忆障碍等症状在逐渐加重。

Families of patients with Alzheimer's disease dementia notice progression from symptoms of disorientation and visual memory disturbance.

机构信息

Kyoto Kaisei Hospital, Kyoto, Japan.

Kyoto Miniren Asukai Hospital, Kyoto, Japan.

出版信息

Psychogeriatrics. 2023 Sep;23(5):747-751. doi: 10.1111/psyg.12991. Epub 2023 Jun 14.

DOI:10.1111/psyg.12991
PMID:37313639
Abstract

BACKGROUND

Alzheimer's disease dementia (ADD) is the most common cognitive disease, but patients' families may notice some symptoms yet not recognise that they indicate ADD. This study investigated the symptoms that families notice as ADD as the disease progresses.

METHODS

New outpatients diagnosed with ADD (n = 315) at five memory clinics completed two cognitive assessments, the Revised Hasegawa Dementia Scale (HDS-R) and Mini-Mental State Examination (MMSE). During an interview, family members completed the Functional Assessment Staging Test (FAST), an observational assessment tool that classifies ADD progression into seven stages. We then examined the relationship of the family-assessed FAST score with clinician-assessed HDS-R and MMSE domain scores by comparing between patients with FAST 1-3 and FAST 4-7. Next, we divided the FAST 4-7 group into the FAST 4-5 and FAST 6-7 subgroups and divided the FAST 1-3 group into the FAST 1-2 and FAST 3 subgroups.

RESULTS

Surprisingly, half of the families did not recognise that the symptoms indicated ADD. Scores for orientation of time and place on the HDS-R and MMSE and for visual memory on the HDS-R were significantly related to family-assessed FAST score. Moreover, the orientation of time and place score on both scales and visual memory on the HDS-R were significantly worse in the FAST 4-7 group than in FAST 1-3 group. In the FAST 4-7 group, scores for age on the HDS-R and for reading and drawing on the MMSE were significantly worse in the FAST 6-7 subgroup. In the analysis of the FAST 1-3 group, there was no significant difference among the HDS-R and MMSE domains between the FAST 1-2 and FAST 3 subgroups.

CONCLUSIONS

Family members of patients with ADD tend to notice the progression of ADD from the symptoms of disorientation and visual memory.

摘要

背景

阿尔茨海默病性痴呆(ADD)是最常见的认知疾病,但患者的家属可能会注意到一些症状,但却没有意识到这些症状表明患有 ADD。本研究调查了随着疾病的进展,家属注意到的 ADD 症状。

方法

在五家记忆诊所新诊断出的 ADD(n=315)患者完成了两项认知评估,即修订后的长谷川痴呆量表(HDS-R)和简易精神状态检查(MMSE)。在访谈过程中,家庭成员完成了功能评估分期测试(FAST),这是一种观察性评估工具,将 ADD 进展分为七个阶段。然后,我们通过比较 FAST 1-3 和 FAST 4-7 患者,比较了家庭成员评估的 FAST 评分与临床医生评估的 HDS-R 和 MMSE 域评分之间的关系。接下来,我们将 FAST 4-7 组分为 FAST 4-5 和 FAST 6-7 亚组,将 FAST 1-3 组分为 FAST 1-2 和 FAST 3 亚组。

结果

令人惊讶的是,一半的家庭没有意识到这些症状表明患有 ADD。HDS-R 和 MMSE 的时间和地点定向以及 HDS-R 的视觉记忆的分数与家庭评估的 FAST 评分显著相关。此外,在 FAST 4-7 组中,HDS-R 的时间和地点定向评分以及 HDS-R 的视觉记忆评分均明显差于 FAST 1-3 组。在 FAST 4-7 组中,HDS-R 的年龄评分以及 MMSE 的阅读和绘画评分在 FAST 6-7 亚组中明显较差。在 FAST 1-3 组的分析中,在 HDS-R 和 MMSE 域之间,FAST 1-2 和 FAST 3 亚组之间没有显著差异。

结论

ADD 患者的家属往往会注意到定向和视觉记忆等症状的 ADD 进展。

相似文献

1
Families of patients with Alzheimer's disease dementia notice progression from symptoms of disorientation and visual memory disturbance.阿尔茨海默病痴呆患者的家属注意到,患者的定向障碍和视觉记忆障碍等症状在逐渐加重。
Psychogeriatrics. 2023 Sep;23(5):747-751. doi: 10.1111/psyg.12991. Epub 2023 Jun 14.
2
Attention to the domains of Revised Hasegawa Dementia Scale and Mini-Mental State Examination in patients with Alzheimer's disease dementia.注意修订后的长谷川痴呆量表和简易精神状态检查在阿尔茨海默病痴呆患者中的领域。
Psychogeriatrics. 2024 May;24(3):582-588. doi: 10.1111/psyg.13100. Epub 2024 Feb 25.
3
Most families tend to realize progress of Alzheimer's disease when behavioural and psychological symptoms are obvious.大多数家庭往往在阿尔茨海默病的行为和心理症状明显时才意识到病情进展。
Psychogeriatrics. 2022 May;22(3):317-323. doi: 10.1111/psyg.12815. Epub 2022 Feb 10.
4
Relationship of the Japanese Old Stories Cognitive Scale With the Revised Hasegawa Cognitive Scale and Mini-Mental State Examination.《日本古故事认知量表与修订版长谷川简易智能状态检查和简易精神状态检查的关系》
J Appl Gerontol. 2024 Nov;43(11):1668-1673. doi: 10.1177/07334648241248339. Epub 2024 Apr 17.
5
Japanese Old Stories Cognitive Scale: a screening test to detect cognitive disease and prompt visiting a memory clinic.日本旧故事认知量表:一种用于筛查认知疾病并促使患者就诊记忆门诊的筛查测试。
Psychogeriatrics. 2019 Jul;19(4):363-369. doi: 10.1111/psyg.12398. Epub 2019 Feb 20.
6
Diagnostic utility of the Addenbrooke's Cognitive Examination - III (ACE-III), Mini-ACE, Mini-Mental State Examination, Montreal Cognitive Assessment, and Hasegawa Dementia Scale-Revised for detecting mild cognitive impairment and dementia.用于检测轻度认知障碍和痴呆的 Addenbrooke 认知测验-III(ACE-III)、Mini-ACE、简易精神状态检查、蒙特利尔认知评估和 Hasegawa 痴呆量表修订版的诊断效用。
Psychogeriatrics. 2020 Mar;20(2):156-162. doi: 10.1111/psyg.12480. Epub 2019 Aug 26.
7
Diagnostic accuracy of mini-mental status examination and revised hasegawa dementia scale for Alzheimer's disease.简易精神状态检查表和修订版长谷川痴呆量表对阿尔茨海默病的诊断准确性。
Dement Geriatr Cogn Disord. 2005;19(5-6):324-30. doi: 10.1159/000084558. Epub 2005 Mar 22.
8
Identification of predictors for mini-mental state examination and revised Hasegawa's Dementia Scale scores using MR-based brain morphometry.使用基于磁共振成像的脑形态测量法识别简易精神状态检查表和修订版长谷川痴呆量表评分的预测因素。
Eur J Radiol Open. 2021 May 24;8:100359. doi: 10.1016/j.ejro.2021.100359. eCollection 2021.
9
Medical interventions suppressed progression of advanced Alzheimer's disease more than mild Alzheimer's disease.医学干预措施对晚期阿尔茨海默病的进展抑制作用强于轻度阿尔茨海默病。
Geriatr Gerontol Int. 2020 Apr;20(4):324-328. doi: 10.1111/ggi.13883. Epub 2020 Feb 10.
10
Relationship between the Montreal Cognitive Assessment and Mini-mental State Examination for assessment of mild cognitive impairment in older adults.蒙特利尔认知评估量表与简易精神状态检查表在评估老年人轻度认知障碍中的关系。
BMC Geriatr. 2015 Sep 7;15:107. doi: 10.1186/s12877-015-0103-3.

引用本文的文献

1
Microbiome Engineering for Biotherapeutic in Alzheimer's Disease Through the Gut-Brain Axis: Potentials and Limitations.通过肠-脑轴进行阿尔茨海默病生物治疗的微生物组工程:潜力与局限
Int J Mol Sci. 2025 Jun 2;26(11):5351. doi: 10.3390/ijms26115351.